People | June 04, 2022
AstraZeneca’s Pascal Soriot awarded British knighthood for services to UK
AstraZeneca also played a critical role in the global response to COVID-19.
AstraZeneca also played a critical role in the global response to COVID-19.
AstraZeneca to invest $50bn in manufacturing and R&D to support domestic sourcing
Facility marks cornerstone of $50 billion investment in medicines R&D and manufacturing in America
Investment will support AstraZeneca’s ambition to reach $80 billion revenue by 2030, with 50% generated in the US
Investment includes biotech agreements with Harbour BioMed, Syneron Bio and BioKangtai
700 new scientific and high-skilled jobs to be created in Greater Toronto Area, investing to execute more than 210 AstraZeneca global clinical studies
Iskra has held leadership positions across Central & Eastern Europe, Eurasia, Middle East & Africa at AstraZeneca
This includes $2 billion of new investment creating more than a thousand new, high-skilled jobs
Operationally ready by 2029, it will be the Company’s first-ever facility to cover the full manufacturing process for ADCs
Launch of 20 new medicines expected by 2030
Subscribe To Our Newsletter & Stay Updated
